<DOC>
	<DOCNO>NCT00335673</DOCNO>
	<brief_summary>- To evaluate control rate Blood Pressure ≤ 140/90 mm Hg non-diabetic patient , ≤ 130/80 mm Hg diabetic patient . - To determine percentage patient achieve blood pressure control accord profile ( naïve , switch , patient history , etc… ) end trial .</brief_summary>
	<brief_title>I SAVE - Irbesartan Mild Moderate Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Patients prove mild moderate hypertension . Newly diagnose `` naïve '' hypertensive patient ( prior treatment hypertension ) OR Patients receive antihypertensive agent ( maximum two one diuretic ) investigator 's opinion would benefit switch study medication . These patient undergo wash period le 7 day prior enrollment . Severe hypertension ( Systolic Blood Pressure ≥ 180 mm Hg Diastolic Blood Pressure ≥ 110 mm Hg ) . Patients secondary hypertension ( another cause type 2 diabetes mellitus ) . Patients HbA1c &gt; 10 % . Significant chronic renal impairment ( Serum creatinine &gt; 2.0 mg/dL ) . Significant liver disease show SGPT/SGOT ( ALAT/ASAT ) &gt; 2.5 time upper limit normal range . Currently pregnant lactating female . Women childbearing potential protected effective contraceptive method birth control and/or unwilling unable test pregnancy . Any patient need combination antihypertensive therapy start ( medical point view physician ) . Known hypersensitivity irbesartan , ARBs ( Angiotensin Receptor Blockers ) , hydrochlorothiazide , thiazide diuretic . Patients malignancy past 5 year , know collagen disease severe cardiac , cerebrovascular gastric disease . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>